ArticleHeart, lung & circulation2026
Characterising Multimorbidity in Adults With Heart Failure: A Latent Class Analysis.
Article in Heart, lung & circulation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
introduction/purposeMultimorbidity (MM) is highly prevalent in patients with heart failure (HF) and associated with worse outcomes; however, our understanding of the heterogeneity of MM in HF is limited. The purpose of this study was to identify and characterise MM classes among adults with HF. METHODS AND
resultsWe conducted a retrospective modified cross-sectional analysis of the combined baseline data repository of adults with New York Heart Association Class I-IV HF enrolled at a single healthcare centre. Comorbidities were assessed with the Charlson Comorbidity Index (CCI), and latent class mixture modeling was used to identify MM classes. Descriptive and comparative statistics were used to characterise classes. The sample (n=523) was 73% male, with an average age of 58.3±14.0 years. Nearly 92% of the sample had at least one additional comorbidity with hypertension (59%), atrial fibrillation (48%), sleep apnoea/disordered breathing (41%), diabetes (40%), and myocardial infarction (36%) as the most prevalent comorbidities. We identified four distinct MM classes of comorbidity dominance: neurovascular-renal (4.5%; oldest, living alone, highest CCI), obesity-metabolic (31.7%; second-oldest, married/partnered, most financial instability), atrial fibrillation (31.9%; lowest CCI), and early comorbidity (31.9%; youngest, second-most financial instability) in patients with HF, each with differences in characteristics.
conclusionsWe found multiple classes of MM with varying characteristics that may have implications for HF management. Coupled with geriatric cardiology principles related to MM, these findings highlight the need to explore the occurrence of MM, including its effects on patient outcomes, and to provide appropriate person-centred care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.